A comparative immunohistochemical study of malignant mesothelioma and renal cell carcinoma: the diagnostic utility of Leu-M1, Ber EP4, Tamm-Horsfall protein and thrombomodulin.
Metastatic renal cell carcinoma has occasionally been reported to mimic malignant pleural mesothelioma. Morphologically, histochemically and immunohistochemically, similarities in the two tumours exist making their differentiation difficult, particularly in biopsy specimens. The aim of this study was to make a comparative immunohistochemical analysis of the two tumours by use of a panel of four antibodies (Leu M1; Ber EP4; thrombomodulin and Tamm-Horsfall protein). Their suitability in differentiating between the two tumours was assessed. We examined 20 cases of renal cell carcinoma and 20 cases of malignant pleural mesothelioma. On immunostaining with Leu M1, 14 of 20 renal cell carcinomas were positive, yielding 70% sensitivity and 95% specificity and one of 20 mesothelioma. In comparison, Ber EP4 antibody stained only seven of 20 of the renal cell carcinomas. In addition, it was noted that four tubulo-papillary pattern renal cell carcinomas stained positively with both anti-Leu M1 antibody and Ber EP4 antibody. Thrombomodulin immunostaining was present in 11 of 20 mesotheliomas (55% sensitivity and demonstrated 95% specificity) and one of 20 renal cell carcinomas. For epithelial mesotheliomas only, thrombomodulin staining was identified in 10 of 14 cases. In the differentiation of renal cell carcinoma from epithelial mesothelioma we recommend the use of Leu M1 and thrombomodulin as diagnostically useful markers. None of the antibodies used in this study was effective in distinguishing sarcomatoid renal cell carcinoma from sarcomatous mesothelioma. Tamm-Horsfall protein showed little diagnostic utility in differentiating the two tumours.
Attanoos
R L
RL
Department of Histopathology, University Hospital of Wales, Cardiff, UK.
Goddard
H
H
Thomas
N D
ND
Jasani
B
B
Gibbs
A R
AR
D000911:Antibodies, Monoclonal / Q000737:chemistry; D000951:Antigens, Neoplasm / Q000032:analysis*; D002292:Carcinoma, Renal Cell / Q000737:chemistry / Q000175:diagnosis / Q000473:pathology*; D003937:Diagnosis, Differential; D006801:Humans; D007680:Kidney Neoplasms / Q000737:chemistry / Q000175:diagnosis / Q000473:pathology*; D016256:Lewis X Antigen / Q000032:analysis*; D008654:Mesothelioma / Q000737:chemistry / Q000175:diagnosis / Q000473:pathology*; D009088:Mucoproteins / Q000032:analysis*; D010997:Pleural Neoplasms / Q000737:chemistry / Q000175:diagnosis / Q000473:pathology*; D018180:Thrombomodulin / Q000032:analysis*; D058949:Uromodulin
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; C117805:Ber-EP4 monoclonal antibody; D016256:Lewis X Antigen; D009088:Mucoproteins; D018180:Thrombomodulin; C548612:UMOD protein, human; D058949:Uromodulin